- Home
- CMPX vs INSI Comparison
CMPX vs INSI Comparison
Compare CMPX & INSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- INSI
- Stock Information
- Founded
- CMPX 2014
- INSI 1971
- Country
- CMPX United States
- INSI United States
- Employees
- CMPX N/A
- INSI N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- INSI Investment Managers
- Sector
- CMPX Health Care
- INSI Finance
- Exchange
- CMPX Nasdaq
- INSI Nasdaq
- Market Cap
- CMPX 217.4M
- INSI 172.0M
- IPO Year
- CMPX N/A
- INSI N/A
- Fundamental
- Price
- CMPX $1.57
- INSI $16.99
- Analyst Decision
- CMPX Strong Buy
- INSI
- Analyst Count
- CMPX 2
- INSI 0
- Target Price
- CMPX $9.00
- INSI N/A
- AVG Volume (30 Days)
- CMPX 413.6K
- INSI 22.0K
- Earning Date
- CMPX 08-12-2024
- INSI 01-01-0001
- Dividend Yield
- CMPX N/A
- INSI 4.90%
- EPS Growth
- CMPX N/A
- INSI N/A
- EPS
- CMPX N/A
- INSI N/A
- Revenue
- CMPX $850,000.00
- INSI N/A
- Revenue This Year
- CMPX N/A
- INSI N/A
- Revenue Next Year
- CMPX $950.68
- INSI N/A
- P/E Ratio
- CMPX N/A
- INSI N/A
- Revenue Growth
- CMPX N/A
- INSI N/A
- 52 Week Low
- CMPX $0.77
- INSI $14.28
- 52 Week High
- CMPX $2.34
- INSI $16.40
- Technical
- Relative Strength Index (RSI)
- CMPX 67.87
- INSI 47.41
- Support Level
- CMPX $1.42
- INSI $16.80
- Resistance Level
- CMPX $1.61
- INSI $17.12
- Average True Range (ATR)
- CMPX 0.12
- INSI 0.25
- MACD
- CMPX 0.03
- INSI -0.03
- Stochastic Oscillator
- CMPX 74.30
- INSI 7.23
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About INSI Insight Select Income Fund
Insight Select Income Fund is a diversified closed-end, management investment company. The fund's investment objective is to seek a high rate of return, primarily from interest income and trading activity, from a portfolio principally consisting of debt securities. It offers various solutions such as risk management, liquidity management, and return generation among others.